Literature DB >> 23242891

Myasthenia gravis during pregnancy.

Shahnaz Akhtar Chaudhry1, Biruthvie Vignarajah, Gideon Koren.   

Abstract

QUESTION: One of my patients who has been diagnosed with myasthenia gravis (MG) is planning pregnancy. Her MG is controlled with medications. Can her condition or her medications adversely affect her pregnancy? ANSWER: The course of MG during pregnancy is unpredictable, but there is no evidence that MG can adversely affect pregnancy outcomes. Examination of most of the medications used for symptom control has so far shown reassuring results. Prepregnancy thymectomy might decrease the need for medications during pregnancy. The newborn should be carefully monitored for signs of transitory MG.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23242891      PMCID: PMC3520659     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  22 in total

1.  Teratogen update: azathioprine and 6-mercaptopurine.

Authors:  Janine E Polifka; J M Friedman
Journal:  Teratology       Date:  2002-05

Review 2.  Myasthenia gravis during pregnancy.

Authors:  Simone Ferrero; Francesca Esposito; Mariangela Biamonti; Giorgio Bentivoglio; Nicola Ragni
Journal:  Expert Rev Neurother       Date:  2008-06       Impact factor: 4.618

3.  Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis.

Authors:  B Bar Oz; R Hackman; T Einarson; G Koren
Journal:  Transplantation       Date:  2001-04-27       Impact factor: 4.939

4.  Myasthenia gravis: management issues during pregnancy.

Authors:  Simone Ferrero; Stefano Pretta; Annamaria Nicoletti; Pasquale Petrera; Nicola Ragni
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2005-08-01       Impact factor: 2.435

Review 5.  An additional patient with mycophenolate mofetil embryopathy: cardiac and facial analyses.

Authors:  Angela E Lin; Kathryn E Singh; Arthur Strauss; Son Nguyen; Kristyn Rawson; Virginia E Kimonis
Journal:  Am J Med Genet A       Date:  2011-03-15       Impact factor: 2.802

6.  Mycophenolate mofetil: emerging as a potential human teratogen.

Authors:  Gideon Koren
Journal:  Can Fam Physician       Date:  2008-08       Impact factor: 3.275

Review 7.  Tetrada of the possible mycophenolate mofetil embryopathy: a review.

Authors:  Paul Merlob; Bracha Stahl; Gil Klinger
Journal:  Reprod Toxicol       Date:  2009-02-25       Impact factor: 3.143

8.  Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs.

Authors:  M Østensen; M Lockshin; A Doria; G Valesini; P Meroni; C Gordon; A Brucato; A Tincani
Journal:  Rheumatology (Oxford)       Date:  2008-06       Impact factor: 7.580

9.  Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study.

Authors:  Chamutal Gur; Orna Diav-Citrin; Svetlana Shechtman; Judy Arnon; Asher Ornoy
Journal:  Reprod Toxicol       Date:  2004 Jan-Feb       Impact factor: 3.143

10.  Myasthenia gravis: a review of available treatment approaches.

Authors:  Nils Erik Gilhus; Jone F Owe; Jana Midelfart Hoff; Fredrik Romi; Geir Olve Skeie; Johan A Aarli
Journal:  Autoimmune Dis       Date:  2011-10-05
View more
  6 in total

1.  Anti-MuSK-positive myasthenia gravis diagnosed during pregnancy: new challenges for an old disease?

Authors:  Ana Raquel Neves; Pitorra Monteiro; Anabela Matos; Isabel Santos Silva
Journal:  BMJ Case Rep       Date:  2015-01-05

Review 2.  Neuro-obstetrics: A multidisciplinary approach to care of women with neurologic disease.

Authors:  Ingrid A Brussé; Anna C M Kluivers; Maria D Zambrano; Kara Shetler; Eliza C Miller
Journal:  Handb Clin Neurol       Date:  2020

Review 3.  Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations.

Authors:  Yang Mao-Draayer; Sandra Thiel; Elizabeth A Mills; Tanuja Chitnis; Michelle Fabian; Ilana Katz Sand; M Isabel Leite; Sven Jarius; Kerstin Hellwig
Journal:  Nat Rev Neurol       Date:  2020-02-20       Impact factor: 42.937

Review 4.  Novel Treatments in Myasthenia Gravis.

Authors:  Deepak Menon; Carolina Barnett; Vera Bril
Journal:  Front Neurol       Date:  2020-06-30       Impact factor: 4.003

5.  Management of Myasthenia Gravis During Pregnancy: A Report of Eight Cases.

Authors:  Beibei Shi; Linchai Zeng
Journal:  Open Life Sci       Date:  2018-04-06       Impact factor: 0.938

Review 6.  Immune System Alterations and Postpartum Mental Illness: Evidence From Basic and Clinical Research.

Authors:  Courtney Dye; Kathryn M Lenz; Benedetta Leuner
Journal:  Front Glob Womens Health       Date:  2022-02-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.